Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04035499 · ClinicalTrials.gov registry record · NA
A Mobile Health Exercise Intervention for Older Patients With Myeloid Neoplasms
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04035499 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 25 participants.
The verdict
NCT04035499, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This is a pilot study to evaluate the feasibility of a mobile health exercise intervention (GO-EXCAP Mobile App) over 7 weeks in 25 patients with myeloid neoplasms receiving hypomethylating agents.
Interventions
- BEHAVIORAL GO-EXCAP Mobile App
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2021-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04035499
The ClinicalTrials.gov registry entry for NCT04035499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GO-EXCAP Mobile App is the first listed.
NCT04035499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04035499 about?
NCT04035499 is a clinical study titled "A Mobile Health Exercise Intervention for Older Patients With Myeloid Neoplasms". This is a pilot study to evaluate the feasibility of a mobile health exercise intervention (GO-EXCAP Mobile App) over 7 weeks in 25 patients with myeloid neoplasms receiving hypomethylating agents.
What is the current status of trial NCT04035499?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2020-02-01. Estimated completion is 2021-10-31.
What interventions are being tested in trial NCT04035499?
The interventions under investigation include: GO-EXCAP Mobile App (BEHAVIORAL).
Who is sponsoring clinical trial NCT04035499?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.